70 related articles for article (PubMed ID: 16198794)
1. Side effects of the biologics.
Heymann WR
J Am Acad Dermatol; 2005 Oct; 53(4):692-3. PubMed ID: 16198794
[No Abstract] [Full Text] [Related]
2. Facial granulomatous nodules during etanercept treatment for psoriasis.
Samimi M; Lorette G; Machet L; de Muret A; Watier H; Maruani A
Int J Dermatol; 2009 Sep; 48(9):1025-7. PubMed ID: 19703000
[No Abstract] [Full Text] [Related]
3. Intermittent dosing of biologics for psoriasis.
Feldman SR
J Dermatolog Treat; 2006; 17(1):5. PubMed ID: 16467016
[No Abstract] [Full Text] [Related]
4. Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
Sumner W; Feldman SR
J Drugs Dermatol; 2007 Oct; 6(10):1048. PubMed ID: 17966185
[TBL] [Abstract][Full Text] [Related]
5. Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis.
Escalas J; Knöpfel N; Martin-Santiago A; Calles C
J Am Acad Dermatol; 2014 Jan; 70(1):e17-8. PubMed ID: 24355280
[No Abstract] [Full Text] [Related]
6. Clinical image: salmonella mycotic aneurysm in a patient receiving etanercept for rheumatoid arthritis.
Qutre A; Demoux AL; Soussan J; Frances Y; Rossi P
Arthritis Rheum; 2012 Mar; 64(3):942. PubMed ID: 22083415
[No Abstract] [Full Text] [Related]
7. Anti-tumor necrosis factor-alpha-induced psoriasis.
Sari I; Akar S; Birlik M; Sis B; Onen F; Akkoc N
J Rheumatol; 2006 Jul; 33(7):1411-4. PubMed ID: 16821276
[TBL] [Abstract][Full Text] [Related]
8. Sensory-motor axonal multineuropathy during etanercept therapy for rheumatoid arthritis.
De Stefano R; Frati E; Volpi N; Galeazzi M
Clin Exp Rheumatol; 2009; 27(2):381. PubMed ID: 19473586
[No Abstract] [Full Text] [Related]
9. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
Conley J; Nanton J; Dhawan S; Pearce DJ; Feldman SR
J Dermatolog Treat; 2006; 17(2):86-9. PubMed ID: 16766332
[TBL] [Abstract][Full Text] [Related]
10. Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment.
Vassilopoulos D; Sialevris K; Malahtari S; Deutsch M; Manolakopoulos S; Archimandritis AJ
J Clin Rheumatol; 2010 Mar; 16(2):88-9. PubMed ID: 20216130
[No Abstract] [Full Text] [Related]
11. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
[No Abstract] [Full Text] [Related]
12. Peripheral mononeuropathy with etanercept use: case report.
Hanaoka BY; Libecco J; Rensel M; Hajj-Ali RA
J Rheumatol; 2008 Jan; 35(1):182. PubMed ID: 18176996
[No Abstract] [Full Text] [Related]
13. Anaphylactic reaction in a patient with rheumatoid arthritis: a rare side effect of methotrexate with etanercept as a provoking factor?
Houtman PM; Jansen TL; Blanken R
J Clin Rheumatol; 2006 Dec; 12(6):321-2. PubMed ID: 17149070
[No Abstract] [Full Text] [Related]
14. Psoriasiform and pustular eruption induced by etanercept and infliximab.
Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
[No Abstract] [Full Text] [Related]
15. Infections and anti-TNF therapy: strategies for screening based on clinical experience.
Estrach C; Abernethy VE; Dawson JK
Rheumatology (Oxford); 2004 Jan; 43(1):115-6; author reply 116. PubMed ID: 14681572
[No Abstract] [Full Text] [Related]
16. Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis.
Michot C; Costes V; Gerard-Dran D; Guillot B; Combes B; Dereure O
Br J Dermatol; 2009 Apr; 160(4):889-90. PubMed ID: 19222452
[No Abstract] [Full Text] [Related]
17. Etanercept for the treatment of psoriasis.
Bissonnette R
Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060
[TBL] [Abstract][Full Text] [Related]
18. Rapid response of nail psoriasis to etanercept.
Rallis E; Stavropoulou E; Rigopoulos D; Verros C
J Rheumatol; 2008 Mar; 35(3):544-5. PubMed ID: 18322982
[No Abstract] [Full Text] [Related]
19. Etanercept and demyelinating disease in a patient with psoriasis.
Sukal SA; Nadiminti L; Granstein RD
J Am Acad Dermatol; 2006 Jan; 54(1):160-4. PubMed ID: 16384777
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
Richette P; Viguier M; Bachelez H; Bardin T
J Rheumatol; 2007 Feb; 34(2):438-9. PubMed ID: 17304662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
